Bristol Myers Squibb to Participate in UBS Virtual Targeted Protein Degradation Day

Rhea-AI Summary

Bristol Myers Squibb (NYSE: BMY) has announced its participation in the UBS Virtual Targeted Protein Degradation Day. The event will feature Robert Plenge, M.D., Ph.D., who is the Executive Vice President, Chief Research Officer, and Head of Research at BMY. Dr. Plenge will be part of a fireside chat on Monday, July 15, 2024, beginning at 11:00 a.m. ET, where he will discuss the company's initiatives and answer questions. Investors and the public can listen to the live webcast via the BMS investor website, with an archived version available after the event.

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in Virtual Targeted Protein Degradation Day hosted by UBS.

Robert Plenge, M.D., Ph.D., Executive Vice President, Chief Research Officer and Head of Research, will take part in a fireside chat on Monday, July 15, 2024. He will answer questions about the company beginning at 11:00 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session by visiting http://investor.bms.com. An archived edition of the session will be available following its conclusion.

About Bristol Myers Squibb Company

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X (formerly Twitter), YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20240708499477/en/

Media:

media@bms.com

Investors:

investor.relations@bms.com

Source: Bristol Myers Squibb

FAQ

When will Bristol Myers Squibb participate in the UBS Virtual Targeted Protein Degradation Day?

Bristol Myers Squibb will participate on Monday, July 15, 2024.

Who from Bristol Myers Squibb will be speaking at the UBS Virtual Targeted Protein Degradation Day?

Robert Plenge, M.D., Ph.D., Executive Vice President, Chief Research Officer, and Head of Research at BMY.

What time does the Bristol Myers Squibb session start at the UBS Virtual Targeted Protein Degradation Day?

The session starts at 11:00 a.m. ET.

How can I watch the Bristol Myers Squibb event during the UBS Virtual Targeted Protein Degradation Day?

You can watch the live webcast by visiting the Bristol Myers Squibb investor website.

Will there be a recording available for the Bristol Myers Squibb session at the UBS Virtual Targeted Protein Degradation Day?

Yes, an archived edition of the session will be available following its conclusion.